Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 40

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 40
---
 ability to commercialize our products or continue our business.

Our ability to raise additional
funds may be adversely impacted by our ability to remain listed on Nasdaq, the potential worsening global economic conditions and disruptions
to and volatility in the credit and financial markets in the United States, including due to bank failures, actual or perceived changes in interest rates and economic inflation, and worldwide resulting from macroeconomic factors.
Because of the numerous risks and uncertainties associated with product development, we cannot predict the timing or amount of increased
expenses and cannot assure you that we will ever be profitable or generate positive cash flow from operating activities.

| 21 |

We may not currently or in the future be able to continue as a going concern.

The financial
statements in this Annual Report have been prepared on a going concern basis of accounting, which assumes that we will continue as a going
concern, and do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company’s
ability to continue as a going concern is dependent on our ability to generate revenues and raise capital. To date, we have not generated
sufficient revenues to provide cash flows that enable us to finance our operations internally. In connection with an evaluation conducted
by our management during the preparation of the financial statements included in this Annual Report, management concluded that there were
conditions and events which raised substantial doubt as to the Company’s ability to continue as a going concern within twelve months
after the date of the issuance of the financial statements included in this Annual Report.

The uncertainty
regarding our ability to continue as a going concern could materially adversely affect our share price and our ability to service our
indebtedness, raise new capital or enter into commercial transactions. To address these matters, we may take actions that materially and
adversely affect our business, including significant reductions in research, development, administrative and commercial activities, reduction
of our employee base, and ultimately curtailing or ceasing operations, any of which could materially adversely affect our business, financial
condition, results of operations and share price. In addition, doubts about our ability to continue as a going concern could impact our
relationships with partners, vendors and other third parties and our ability to obtain, maintain or renew contracts with them, or negatively
impact our negotiating leverage with such parties, which could have a material adverse effect on our business, financial condition and
results of operations. Furthermore, any loss of key personnel, employee attrition or material erosion of employee morale arising out of